OBJECTIVES: To evaluate the contribution of multiple medical comorbidities on the overall survival of endometrial cancer patients. METHODS: The study evaluated 490 endometrial cancer patients stages I to IV who were treated between 1992 and 2008 with a hysterectomy with or without radiation therapy (RT). Hazard ratios (HR) were calculated for multiple variables including: diabetes mellitus (DM), hypertension (HTN), body mass index, smoking, RT, and years of estrogen exposure and then recalculated with an adjustment for age and grade as potential confounders. RESULTS: In this study, 47% of patients had HTN, 26% had DM, 11% were smokers, 64% were stage I, 39% were grade 1, and 36% received RT. The presence of DM and HTN on univariate analysis resulted in decreased survival with [HR 1.70; 95% confidence interval (CI), 1.18-2.46] and (HR 1.66; 95% CI, 1.17-2.36), respectively. On multivariate analysis after correction for stage, age, and grade, DM and HTN continued to show a reduced survival rate (HR 1.58; 95% CI, 1.07-2.33 and HR 1.51; 95% CI, 1.06-2.15, respectively). Body mass index, smoking, parity, age at menarche, and years of estrogen exposure did not affect survival before or after correction for stage, age, and grade. CONCLUSIONS: In this study, DM and HTN adversely effected survival. Given the favorable survival rate for most patients with endometrial cancer, attention to comorbid conditions, and particularly DM and HTN, is becoming more relevant for its implications on current health care and policy.
OBJECTIVES: To evaluate the contribution of multiple medical comorbidities on the overall survival of endometrial cancerpatients. METHODS: The study evaluated 490 endometrial cancerpatients stages I to IV who were treated between 1992 and 2008 with a hysterectomy with or without radiation therapy (RT). Hazard ratios (HR) were calculated for multiple variables including: diabetes mellitus (DM), hypertension (HTN), body mass index, smoking, RT, and years of estrogen exposure and then recalculated with an adjustment for age and grade as potential confounders. RESULTS: In this study, 47% of patients had HTN, 26% had DM, 11% were smokers, 64% were stage I, 39% were grade 1, and 36% received RT. The presence of DM and HTN on univariate analysis resulted in decreased survival with [HR 1.70; 95% confidence interval (CI), 1.18-2.46] and (HR 1.66; 95% CI, 1.17-2.36), respectively. On multivariate analysis after correction for stage, age, and grade, DM and HTN continued to show a reduced survival rate (HR 1.58; 95% CI, 1.07-2.33 and HR 1.51; 95% CI, 1.06-2.15, respectively). Body mass index, smoking, parity, age at menarche, and years of estrogen exposure did not affect survival before or after correction for stage, age, and grade. CONCLUSIONS: In this study, DM and HTN adversely effected survival. Given the favorable survival rate for most patients with endometrial cancer, attention to comorbid conditions, and particularly DM and HTN, is becoming more relevant for its implications on current health care and policy.
Authors: Julie J Ruterbusch; Rouba Ali-Fehmi; Sara H Olson; Shawnita Sealy-Jefferson; Benjamin A Rybicki; Sharon Hensley-Alford; Mohamed A Elshaikh; Arthur R Gaba; Daniel Schultz; Adnan R Munkarah; Michele L Cote Journal: Am J Obstet Gynecol Date: 2014-06-19 Impact factor: 8.661
Authors: Pratibha S Binder; Jeffrey F Peipert; D Kallogjeri; Rebecca A Brooks; L Stewart Massad; David G Mutch; Matthew A Powell; Premal H Thaker; Carolyn K McCourt Journal: Am J Obstet Gynecol Date: 2016-07-22 Impact factor: 8.661
Authors: Ashley S Felix; D Scott McMeekin; David Mutch; Joan L Walker; William T Creasman; David E Cohn; Shamshad Ali; Richard G Moore; Levi S Downs; Olga B Ioffe; Kay J Park; Mark E Sherman; Louise A Brinton Journal: Gynecol Oncol Date: 2015-09-01 Impact factor: 5.482
Authors: Yael N Kusne; Heidi E Kosiorek; Matthew R Buras; Kyle E Coppola; Patricia M Verona; Curtiss B Cook; Nina J Karlin Journal: Future Sci OA Date: 2020-12-18
Authors: Fausto Petrelli; Alessio Cortellini; Alice Indini; Gianluca Tomasello; Michele Ghidini; Olga Nigro; Massimiliano Salati; Lorenzo Dottorini; Alessandro Iaculli; Antonio Varricchio; Valentina Rampulla; Sandro Barni; Mary Cabiddu; Antonio Bossi; Antonio Ghidini; Alberto Zaniboni Journal: JAMA Netw Open Date: 2021-03-01